Breakthrough in Neuro-Oncology: Vitamin B12 Derivative Shows Promise Against Glioblastoma
Glioblastoma multiforme (GBM) has long been considered the "final frontier" of oncology. As the most aggressive and malignant form of primary brain cancer, its clinical prognosis remains grim. Despite the aggressive standard-of-care…